We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Report Pins Manufacturing Woes on Acquisition as Pharma Ups M&A
J&J Report Pins Manufacturing Woes on Acquisition as Pharma Ups M&A
August 1, 2011
Johnson & Johnson’s (J&J) ongoing manufacturing issues can largely be pinned on mistakes made during its Pfizer Consumer Healthcare (PCH) acquisition, a special J&J committee says — just as pharma execs predict a slew of M&A activity over the next two years.